Ba679BR Powder Inhalation

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ba679BR Powder Inhalation, covering 2014-06-24 to 2014-06-24. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Ba679BR Powder Inhalation in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]

See pricing